| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |